Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability.
Journal articles
- Journal Article
Hung, A; Gross, CP
Published in: JAMA Intern Med
July 1, 2026
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
July 1, 2026
Volume
186
Issue
7
Start / End Page
801 / 802
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Hung, A., & Gross, C. P. (2026). Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability. JAMA Intern Med, 186(7), 801–802. https://doi.org/10.1001/jamainternmed.2026.0987
Hung, Anna, and Cary P. Gross. “Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability.” JAMA Intern Med 186, no. 7 (July 1, 2026): 801–2. https://doi.org/10.1001/jamainternmed.2026.0987.
Hung A, Gross CP. Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability. JAMA Intern Med. 2026 Jul 1;186(7):801–2.
Hung, Anna, and Cary P. Gross. “Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability.” JAMA Intern Med, vol. 186, no. 7, July 2026, pp. 801–02. Pubmed, doi:10.1001/jamainternmed.2026.0987.
Hung A, Gross CP. Patent Listing Challenges by the Federal Trade Commission: A New Approach to Promoting Drug Affordability. JAMA Intern Med. 2026 Jul 1;186(7):801–802.
Published In
JAMA Intern Med
DOI
EISSN
2168-6114
Publication Date
July 1, 2026
Volume
186
Issue
7
Start / End Page
801 / 802
Location
United States
Related Subject Headings
- 4203 Health services and systems
- 3202 Clinical sciences